George Oliver Sells 184,331 Shares of Johnson Controls International plc (NYSE:JCI) Stock

Johnson Controls International plc (NYSE:JCI) Director George Oliver sold 184,331 shares of the stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $79.49, for a total transaction of $14,652,471.19. Following the completion of the transaction, the director now directly owns 1,019,562 shares of the company’s stock, valued at approximately $81,044,983.38. The trade was a 15.31 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

George Oliver also recently made the following trade(s):

• On Friday, March 14th, George Oliver sold 15,669 shares of Johnson Controls International stock. The shares were sold at an average price of $77.49, for a total value of $1,214,190.81.
• On Tuesday, February 25th, George Oliver sold 129,263 shares of Johnson Controls International stock. The stock was sold at an average price of $83.55, for a total transaction of $10,799,923.65.
• On Friday, February 14th, George Oliver sold 162,894 shares of Johnson Controls International stock. The stock was sold at an average price of $89.28, for a total transaction of $14,543,176.32.
• On Monday, February 10th, George Oliver sold 205,168 shares of Johnson Controls International stock. The shares were sold at an average price of $89.07, for a total transaction of $18,274,313.76.
• On Friday, February 7th, George Oliver sold 205,168 shares of Johnson Controls International stock. The stock was sold at an average price of $88.03, for a total value of $18,060,939.04.

Johnson Controls International Price Performance

Shares of JCI traded up $2.32 during mid-day trading on Friday, hitting $79.78. 4,693,925 shares of the stock were exchanged, compared to its average volume of 4,219,735. The firm has a 50-day moving average of $82.41 and a two-hundred day moving average of $79.61. Johnson Controls International plc has a 52-week low of $59.83 and a 52-week high of $91.14. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.86 and a current ratio of 1.02. The company has a market cap of $52.67 billion, a PE ratio of 30.45, a price-to-earnings-growth ratio of 1.96 and a beta of 1.32.

Johnson Controls International (NYSE:JCI) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.59 by $0.05. Johnson Controls International had a return on equity of 15.11% and a net margin of 6.83%. On average, equities analysts predict that Johnson Controls International plc will post 3.64 earnings per share for the current year.

Johnson Controls International Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 17th. Shareholders of record on Monday, March 24th will be paid a $0.37 dividend. This represents a $1.48 annualized dividend and a yield of 1.86%. The ex-dividend date is Monday, March 24th. Johnson Controls International’s payout ratio is currently 56.49%.

Analysts Set New Price Targets

Several research firms have commented on JCI. JPMorgan Chase & Co. boosted their target price on Johnson Controls International from $87.00 to $100.00 and gave the stock an “overweight” rating in a report on Thursday, February 6th. Morgan Stanley raised their price target on shares of Johnson Controls International from $95.00 to $105.00 and gave the company an “overweight” rating in a report on Thursday, February 6th. StockNews.com downgraded Johnson Controls International from a “buy” rating to a “hold” rating in a research note on Wednesday, November 20th. Wells Fargo & Company upped their price target on shares of Johnson Controls International from $92.00 to $98.00 and gave the company an “overweight” rating in a research report on Thursday, February 6th. Finally, Barclays reduced their price target on Johnson Controls International from $88.00 to $85.00 and set an “equal weight” rating for the company in a research report on Monday. Eight equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $91.27.

Institutional Trading of Johnson Controls International

Large investors have recently made changes to their positions in the stock. Assetmark Inc. lifted its position in shares of Johnson Controls International by 1.2% in the 3rd quarter. Assetmark Inc. now owns 32,913 shares of the company’s stock worth $2,554,000 after purchasing an additional 400 shares during the period. Ashton Thomas Securities LLC acquired a new stake in shares of Johnson Controls International during the third quarter worth about $61,000. Nations Financial Group Inc. IA ADV acquired a new position in Johnson Controls International in the 3rd quarter worth approximately $324,000. Apollon Wealth Management LLC lifted its stake in Johnson Controls International by 21.6% during the 3rd quarter. Apollon Wealth Management LLC now owns 19,977 shares of the company’s stock valued at $1,550,000 after acquiring an additional 3,554 shares during the period. Finally, Harbour Investments Inc. boosted its holdings in shares of Johnson Controls International by 12.7% in the 3rd quarter. Harbour Investments Inc. now owns 2,866 shares of the company’s stock valued at $222,000 after acquiring an additional 322 shares during the last quarter. 90.05% of the stock is owned by hedge funds and other institutional investors.

Johnson Controls International Company Profile

Johnson Controls International plc, together with its subsidiaries, engages in engineering, manufacturing, commissioning, and retrofitting building products and systems in the United States, Europe, the Asia Pacific, and internationally. It operates in four segments: Building Solutions North America, Building Solutions EMEA/LA, Building Solutions Asia Pacific, and Global Products.